Comments
Loading...
SCANDI STD AB by Scandi STD AB Analyst Ratings and Price Targets | OTC:SCANF | Benzinga
SCANDI STD AB by Scandi STD AB Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for SCANDI STD AB by Scandi STD AB Corp from these most-recent analyst ratings.
Analyst Ratings for SCANDI STD AB by Scandi STD AB
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for SCANDI STD AB by Scandi STD AB (SCANF) stock?
There is no price target for SCANDI STD AB by Scandi STD AB
What is the most recent analyst rating for SCANDI STD AB by Scandi STD AB (SCANF)?
There is no analyst for SCANDI STD AB by Scandi STD AB
When was the last upgrade for SCANDI STD AB by Scandi STD AB (SCANF)?
There is no last upgrade for SCANDI STD AB by Scandi STD AB
When was the last downgrade for SCANDI STD AB by Scandi STD AB (SCANF)?
There is no last downgrade for SCANDI STD AB by Scandi STD AB.
When is the next analyst rating going to be posted or updated for SCANDI STD AB by Scandi STD AB (SCANF)?
There is no next analyst rating for SCANDI STD AB by Scandi STD AB.
Is the Analyst Rating SCANDI STD AB by Scandi STD AB (SCANF) correct?
There is no next analyst rating for SCANDI STD AB by Scandi STD AB.
Browse analyst ratings and price targets on all stocks.
